An in vitro study by Suto et al. (2015) showed miR-7 overexpression increased sensitivity to cetuximab in HCT-116 and SW480 cetuximab-resistant CRC cells harbouring a Kirsten rat sarcoma viral oncogene homolog (KRAS) mutation. Here, KRAS is linked to colorectal carcinoma.